Company: SYRA
Filing Date: 2025-09-19
Form Type: DEF 14A
Source: 0001493152-25-014246
Chunk: 24

Company: Syra Health Corp
Filing Date: 2025-09-19
Form: DEF 14A
Chunk 24
---
113 |     | $         | - |     | $                | - |     | $                 | - |     | $                                         | - |     | $                                               | - |     | $                             |  8,094 |     | $     | 226,207 |
| Priya Prasad,                                    |     | 2024 |     | $          | 164,703 |     | $         | - |     | $                | - |     | $                 | - |     | $                                         | - |     | $                                               | - |     | $                             |  6,588 |     | $     | 171,291 |
| Chief Operating Officer, Chief Financial Officer |     | 2023 |     | $          | 147,115 |     | $         | - |     | $                | - |     | $                 | - |     | $                                         | - |     | $                                               | - |     | $                             |  6,135 |     | $     | 153,250 |

(1)The amounts in this column represent the Company’s 401(k) plan Company-matching contributions for each named executive officer.

Outstanding Equity Awards at December 31, 2024

There were no outstanding equity awards held by our named executive officers as of December 31, 2024.

Equity Award Grant Timing

We do nothave a written policy in place regarding the timing of the grant and issuance of stock options in relation to the release of material non-public information. Historically, we have granted stock option awards as may be deemed appropriate by our Board or compensation committee from time to time based on the facts and circumstances, as applicable. We have notintentionally timed the grant of stock options in anticipation of the release of material nonpublic information, nor have we intentionally timed the release of material nonpublic information based on stock option grant dates.

| 15 |

Employment Agreements

Deepika Vuppalanchi

On April 15, 2021, the Company entered into an employment agreement with Deepika Vuppalanchi, which was subsequently amended by (i) that certain Amendment No. 1 thereto dated September 1, 2021; (ii) that certain Amendment No. 2 thereto dated March 1, 2022; and (iii) that certain Amendment No. 3 thereto dated October 18, 2022 (as amended, the “V